Acumen Pharmaceuticals Inc - Company Review
Acumen Pharmaceuticals Inc - Company ReviewSummary
Acumen Pharmaceuticals Inc (Acumen) is a pharmaceutical company that discovers and develops therapeutics and diagnostics services for the treatment of Alzheimer’s disease and other related neurodegenerative conditions. It focuses on development of ADDL (amyloid-beta derived diffusible ligands)-Select antibodies that target soluble amyloid-beta (A-beta) oligomers that inhibit nerve function, trigger early memory deficits and starts nerve degeneration and downstream pathological events in Alzheimer’s. The company’s lead candidate ACU-193, an anti-ADDL antibody is in preclinical development stage. Acumen has also developed an ultra-high sensitivity assay for detection of soluble amyloid-beta (A-beta) oligomers versus amyloid-beta (A-beta) monomers. The company owns intellectual property for soluble A-beta oligomers, ADDLs and related therapeutics and diagnostics. Acumen is headquartered in Livermore, California, the US.
This comprehensive company report of Acumen Pharmaceuticals Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.